Erica Johnson to Humans
This is a "connection" page, showing publications Erica Johnson has written about Humans.
Connection Strength
0.168
-
Williams A, Hossack DJ, Thompson N, Sim YE, Wilson C, Schuch V, Hailstorks T, Chakraborty R, Johnson EL. Elevated levels of exogenous prolactin promote inflammation at the maternal-fetal interface via the JAK2/STAT5B signaling axis. Front Immunol. 2024; 15:1496610.
Score: 0.040
-
Joseph TT, Schuch V, Hossack DJ, Chakraborty R, Johnson EL. Melatonin: the placental antioxidant and anti-inflammatory. Front Immunol. 2024; 15:1339304.
Score: 0.037
-
Johnson EL, Swieboda D, Olivier A, Enninga EAL, Chakraborty R. Robust innate immune responses at the placenta during early gestation may limit in utero HIV transmission. PLoS Pathog. 2021 08; 17(8):e1009860.
Score: 0.032
-
Johnson EL, Singh R, Singh S, Johnson-Holiday CM, Grizzle WE, Partridge EE, Lillard JW. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion. World J Surg Oncol. 2010 Jul 22; 8:62.
Score: 0.015
-
Huang MB, Yan F, Jadoon U, Wu JY, Brena D, Johnson EL, Stiles J, Yang L, Rivers BM, Bond VC. SMR Peptide Modulates Tumor-Derived Extracellular Vesicles microRNA and Inflammatory Transcript Signatures in TNBC. Cells. 2026 Mar 19; 15(6).
Score: 0.011
-
Awai A, Johnson EL, Leng T, Patrickson J, Zody MC, Lillard JW. Stratifying ALS Patients by Mode of Inheritance Reveals Transcriptomic Signatures Specific to sALS and fALS. Int J Mol Sci. 2025 Sep 22; 26(18).
Score: 0.010
-
Huang MB, Tiwari PB, ?ren A, Shelton MN, Brena D, Wu JY, Khan MB, Powell MD, Stiles JK, Johnson EL, Yan F, Yang L, Bond VC. Investigating SMR Peptide Interactions with Breast Cancer-Associated Proteins. Int J Mol Sci. 2025 Sep 11; 26(18).
Score: 0.010
-
Lin X, Geng R, Menke K, Edelson M, Yan F, Leong T, Rust GS, Waller LA, Johnson EL, Cheng Immergluck L. Machine learning to predict risk for community-onset Staphylococcus aureus infections in children living in southeastern United States. PLoS One. 2023; 18(9):e0290375.
Score: 0.009
-
Johnson-Holiday C, Singh R, Johnson EL, Grizzle WE, Lillard JW, Singh S. CCR9-CCL25 interactions promote cisplatin resistance in breast cancer cell through Akt activation in a PI3K-dependent and FAK-independent fashion. World J Surg Oncol. 2011 May 03; 9:46.
Score: 0.004